Skip to main content
. 2018 Jan 20;45(3):355–364. doi: 10.1007/s10928-018-9571-3

Fig. 3.

Fig. 3

Median (95% CI) of estimated proportion of patients achieving ≥ 80% inhibition of TRAP-induced platelet aggregation based on Monte Carlo simulations utilizing the population PK and PK/PD models assuming two differing estimates of in vivo potency (EC50) from the modeling analysis.

Reproduced with permission from Gheyas et al. [16]